The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 10, 2024
Filed:
Jun. 24, 2022
Korea Research Institute of Chemical Technology, Daejeon, KR;
Ubix Therapeutics, Inc., Seoul, KR;
Pil Ho Kim, Daejeon, KR;
Sung Yun Cho, Daejeon, KR;
Jae Du Ha, Daejeon, KR;
Chi Hoon Park, Daejeon, KR;
Jong Yeon Hwang, Daejeon, KR;
Hyun Jin Kim, Daejeon, KR;
Song Hee Lee, Seoul, KR;
Ye Seul Lim, Seoul, KR;
Han Wool Kim, Seoul, KR;
Sun Mi Yoo, Seoul, KR;
Beom Seon Suh, Seongnam-si, KR;
Ji Youn Park, Seongnam-si, KR;
Je Ho Ryu, Seongnam-si, KR;
Jung Min Ahn, Incheon, KR;
Hee Jung Moon, Incheon, KR;
Ho Hyun Lee, Siheung-si, KR;
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY, Daejeon, KR;
UBIX THERAPEUTICS, INC., Seoul, KR;
Abstract
The present invention relates to a novel heterocyclic compound and a composition, for preventing or treating a cancer, an autoimmune disease, and an inflammatory disease, comprising same. The novel heterocyclic compound of the present invention is a bifunctional compound having a Bruton's tyrosine kinase (BTK) degradation function via a ubiquitin proteasome pathway, and may be utilized as a composition for preventing or treating a cancer, an autoimmune disease, and Parkinson's disease.